L-656224 is a potent, selective, and orally active inhibitor of leukotriene biosynthesis in intact rat and human leukocytes as well as CXBG mastocytoma cells (IC50 = 18–240 nM), and inhibits 5-lipoxygenase in human and porcine leukocytes (IC50 = 4 × 10⁻⁷ M); it shows potential for research in asthma and as a peripheral analgesic agent.